Recent Advances in Signal Amplification to Improve Electrochemical Biosensing for Infectious Diseases

Abstract

The field of infectious disease diagnostics is burdened by inequality in access to healthcare resources. In particular, “point-of-care” (POC) diagnostics that can be utilized in non-laboratory, sub-optimal environments are appealing for disease control with limited resources. Electrochemical biosensors, which combine biorecognition elements with electrochemical readout to enable sensitive and specific sensing using inexpensive, simple equipment, are a major area of research for the development of POC diagnostics. To improve the limit of detection (LOD) and selectivity, signal amplification strategies have been applied towards these sensors. In this perspective, we review recent advances in electrochemical biosensor signal amplification strategies for infectious disease diagnostics, specifically biosensors for nucleic acids and pathogenic microbes. We classify these strategies into target-based amplification and signal-based amplification. Target-based amplification strategies improve the LOD by increasing the number of detectable analytes, while signal-based amplification strategies increase the detectable signal by modifying the transducer system and keep the number of targets static. Finally, we argue that signal amplification strategies should be designed with application location and disease target in mind, and that the resources required to produce and operate the sensor should reflect its proposed application, especially when the platform is designed to be utilized in low-resource settings. We anticipate that, based on current technologies to diagnose infectious diseases, incorporating signal-based amplification strategies will enable electrochemical POC devices to be deployed for illnesses in a wide variety of settings.

Detection of abemaciclib, an anti-breast cancer agent, using a new electrochemical DNA biosensor

“…The sensor functionalization can be prospective method to monitor the conventional drug dosage (Bayraktepe, 2020;Fathi et al, 2020;Foroughi et al, 2021a;Foroughi et al, 2015;Li et al, 2022;Maaref et al, 2018;Moarefdoust et al, 2021). Nanomaterials have shown specific physical and chemical characteristics in a variety of fields (Akca et al, 2021;Farvardin et al, 2020;Foroughi and Jahani, 2022;Foroughi and Ranjbar, 2017;Mei et al, 2022;Salajegheh et al, 2019;Zhou et al, 2022).…”

Molecular Amplification as an Affordable Strategy for Trace‐Level Detection of Ionic Analytes with Fluorimetric or Colorimetric Readout

“…Similarly, as the name suggests, in signal amplification, the signal produced from a single analyte‐receptor recognition event is enhanced by involving an amplifier [22] . On the contrary, in the case of receptor amplification, a number of scaffolds get involved in a single binding event, therefore modifying the optoelectronic properties of the entire system [23] …”

“…[22] On the contrary, in the case of receptor amplification, a number of scaffolds get involved in a single binding event, therefore modifying the optoelectronic properties of the entire system. [23] Abhijnan Ray Choudhury received his B.Sc. degree (Chemistry Hons.)…”

Carbon Electrode-Based Biosensing Enabled by Biocompatible Surface Modification with DNA and Proteins

“…Biomolecules are increasingly employed in electrochemical systems for sensing, , sustainability, − and energy. , As the complexity of bioelectrochemical systems increases, so does the burden on surface modification strategies . The methods used for their immobilization on electrodes are therefore ever more important.…”

“…The integrity of the biomolecules is essential for the performance of these devices, and harsh chemical reactions can damage DNA or denature proteins. Additionally, noncovalent adhesion has been shown to decrease the sensitivity of bioelectrochemical detection platforms. ,− Thus, despite the promise of many of these technologies, their commercialization beyond the glucose meter has remained limited …”